Discontinued drugs in 2008: oncology drugs

被引：18
|
作者：
Williams, Robert [1 ]
机构：
[1] Canc Res UK, Drug Dev Off, London WC2A 3PX, England
来源：
EXPERT OPINION ON INVESTIGATIONAL DRUGS | 2009年 / 18卷 / 11期
关键词：
1D09C3; 4-demethylpenclomedine; ARQ-171; AZD-4992; CNF-1010; DN-101; FCE-28068; FCE-28069; folitixorin calcium; huMy9-6-DM4; INNO-305; mitumprotimut-T; MLN-8054; N-acetylcysteine; PD-0325901; phosphomannopentaose sulfate; PI-166; SGX-523; spisulosine; Symadex; tozasertib lactate; varalanib; zanolimumab; ATTRITION RATES;
D O I：
10.1517/13543780903151806
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The failure of drug candidates in clinical development remains a critical issue for the pharmaceutical and biotechnology industries. This article documents those oncology drugs discontinued in 2008 and briefly reviews reasons for termination of development. Source information was derived from a search of the Pharmaprojects database for drugs reaching phase I - III clinical trials.
引用
收藏
页码：1581 / 1594
页数：14
相关论文
共 50 条
  • [11] Discontinued drugs in 2008: endocrine and metabolic
    Colca, Jerry R.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (09) : 1243 - 1255
  • [12] Discontinued drugs 2008: pulmonary and allergy
    Antoniu, Sabina A.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (12) : 1799 - 1805
  • [13] Discontinued drugs in 2008: anti-infectives
    Ryder, Neil S.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2010, 19 (01) : 1 - 21
  • [14] Discontinued drugs in 2011: cardiovascular drugs
    Zhao, Hong-Ping
    Jiang, Hong-Min
    Xiang, Bing-Ren
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2012, 21 (10) : 1449 - 1462
  • [15] Discontinued drugs in 2005: schizophrenia drugs
    Kerwin, Robert
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2006, 15 (12) : 1487 - 1495
  • [16] Discontinued drugs in 2012: cardiovascular drugs
    Zhao, Hong-Ping
    Jiang, Hong-Min
    Xiang, Bing-Ren
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2013, 22 (11) : 1437 - 1451
  • [17] Discontinued drugs in 2007: cardiovascular drugs
    Zhang Xu-song
    Xiang Bing-ren
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2008, 17 (12) : 1817 - 1828
  • [18] Discontinued drugs in 2005: cardiovascular drugs
    Suckling, Keith
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2006, 15 (11) : 1299 - 1308
  • [19] Discontinued drugs in 2010: cardiovascular drugs
    Zhao, Hong-ping
    Zhang, Xu-song
    Xiang, Bing-ren
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2011, 20 (10) : 1311 - 1325
  • [20] Discontinued drugs in 2006: renal, endocrine and metabolic drugs
    Colca, Jerry R.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (10) : 1517 - 1523
12345